These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1595650)

  • 1. Fecal lysozyme: an unreliable marker for colorectal cancer.
    Dubrow R; Kim CS; Eldred AK
    Am J Gastroenterol; 1992 May; 87(5):617-21. PubMed ID: 1595650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testing of multiple samples increases the sensitivity of stool decay-accelerating factor test for the detection of colorectal cancer.
    Mizuno M; Mizuno M; Iwagaki N; Nasu J; Okazaki H; Yamamoto K; Okada H; Tsuji T; Fujita T; Shiratori Y
    Am J Gastroenterol; 2003 Nov; 98(11):2550-5. PubMed ID: 14638362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of fecal pyruvate kinase type M2 (tumor M2-PK) concentrations in patients with gastric cancer, colorectal cancer, colorectal adenomas and controls.
    Hardt PD; Toepler M; Ngoumou B; Rupp J; Kloer HU
    Anticancer Res; 2003; 23(2A):851-3. PubMed ID: 12820312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal protein markers of colorectal cancer.
    Dubrow R; Yannielli L
    Am J Gastroenterol; 1992 Jul; 87(7):854-8. PubMed ID: 1615938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal Adnab-9 binding as a risk marker for colorectal neoplasia.
    Yuan M; Xhang X; Leu Y; Xu Y; Ullah N; Lawson M; Tobi M
    Cancer Lett; 2006 Apr; 235(1):48-52. PubMed ID: 15893419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of calgranulin B in stools from the patients with colorectal cancer.
    Yoo BC; Shin YK; Lim SB; Hong SH; Jeong SY; Park JG
    Dis Colon Rectum; 2008 Nov; 51(11):1703-9. PubMed ID: 18584251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of alkaline sphingomyelinase activity in human stool: proposed role as a new diagnostic and prognostic marker of colorectal cancer.
    Di Marzio L; Di Leo A; Cinque B; Fanini D; Agnifili A; Berloco P; Linsalata M; Lorusso D; Barone M; De Simone C; Cifone MG
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):856-62. PubMed ID: 15824156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal cyclooxygenase 2 plus matrix metalloproteinase 7 mRNA assays as a marker for colorectal cancer screening.
    Takai T; Kanaoka S; Yoshida K; Hamaya Y; Ikuma M; Miura N; Sugimura H; Kajimura M; Hishida A
    Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1888-93. PubMed ID: 19505922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential role of fecal carbonic anhydrase II in screening for colorectal cancer.
    Yokoyama S; Shatney CH; Mochizuki H; Hase K; Johnson DL; Cummings S; Trollope ML; Tamakuma S
    Am Surg; 1997 Mar; 63(3):243-6; discussion 246-7. PubMed ID: 9036892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of different stool tests for the detection of cancer of the colon].
    Vogel T; Driemel C; Hauser A; Hansmann A; Lange S; Jonas M; Möslein G
    Dtsch Med Wochenschr; 2005 Apr; 130(14):872-7. PubMed ID: 15800820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of determining lysozyme in colorectal cancer.
    Tichý M; Bures J; Jandík P
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1990; 33(3):345-9. PubMed ID: 2087630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnostic value of G-CSF measurement in the sera of colorectal cancer and adenoma patients.
    Mroczko B; Groblewska M; Wereszczynska-Siemiatkowska U; Kedra B; Konopko M; Szmitkowski M
    Clin Chim Acta; 2006 Sep; 371(1-2):143-7. PubMed ID: 16603145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA stool test for colorectal cancer: hypermethylation of the secreted frizzled-related protein-1 gene.
    Zhang W; Bauer M; Croner RS; Pelz JO; Lodygin D; Hermeking H; Stürzl M; Hohenberger W; Matzel KE
    Dis Colon Rectum; 2007 Oct; 50(10):1618-26; discussion 1626-7. PubMed ID: 17762966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of hypermethylated DNA or cyclooxygenase-2 messenger RNA in fecal samples of patients with colorectal cancer or polyps.
    Leung WK; To KF; Man EP; Chan MW; Hui AJ; Ng SS; Lau JY; Sung JJ
    Am J Gastroenterol; 2007 May; 102(5):1070-6. PubMed ID: 17378912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
    Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
    J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal pyruvate kinase concentrations (ELISA based on a combination of clone 1 and clone 3 antibodies) for gastric cancer screening.
    Hardt PD; Toepler M; Ngoumou B; Rupp J; Kloer HU
    Anticancer Res; 2003; 23(2A):855-7. PubMed ID: 12820313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new fecal calprotectin test for colorectal neoplasia. Clinical results and comparison with previous method.
    Johne B; Kronborg O; Tøn HI; Kristinsson J; Fuglerud P
    Scand J Gastroenterol; 2001 Mar; 36(3):291-6. PubMed ID: 11305517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrointestinal tract cancer screening using fecal carcinoembryonic antigen.
    Kim Y; Lee S; Park S; Jeon H; Lee W; Kim JK; Cho M; Kim M; Lim J; Kang CS; Han K
    Ann Clin Lab Sci; 2003; 33(1):32-8. PubMed ID: 12661896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection of protein p53 in the stool of patients with colorectal cancer].
    Jaïs P; Kapel N; Chosidow D; Rupaire N; Rougier P; Lasser P; Mignon M; Lewin MJ; Gobert JG
    Gastroenterol Clin Biol; 1997; 21(10):754-9. PubMed ID: 9587516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The forms and the levels of fecal PMN-elastase in patients with colorectal diseases.
    Saitoh O; Sugi K; Matsuse R; Uchida K; Matsumoto H; Nakagawa K; Takada K; Yoshizumi M; Hirata I; Katsu K
    Am J Gastroenterol; 1995 Mar; 90(3):388-93. PubMed ID: 7872275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.